Burnaby, Canada

Ian Nevin Foltz

USPTO Granted Patents = 67 

 

 

Average Co-Inventor Count = 6.9

ph-index = 13

Forward Citations = 655(Granted Patents)

Forward Citations (Not Self Cited) = 595(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Vancouver, CA (2007 - 2008)
  • Barnaby, CA (2016)
  • British Columbia, CA (2012 - 2021)
  • Thousand Oaks, CA (US) (2022 - 2023)
  • Burnaby, CA (2007 - 2024)

Company Filing History:


Years Active: 2007-2025

Loading Chart...
Loading Chart...
Loading Chart...
67 patents (USPTO):

As a client of idiyas.com, I am pleased to present an article about the innovative inventor Ian Nevin Foltz:

Title: Driving Medical Advancements: The Inventor Ian Nevin Foltz

Introduction:

Ian Nevin Foltz is a distinguished inventor based in Burnaby, California, renowned for his groundbreaking work in the field of biochemistry and pharmaceuticals. With an impressive portfolio of 63 patents to his name, Foltz continues to push the boundaries of medical innovation.

Latest Patents:

Foltz's recent patents showcase his commitment to advancing medical treatments. Notable among these is the patent for 'Interleukin-2 muteins for the expansion of T-regulatory cells,' which involves innovative IL-2 muteins and Fc-fusion molecules designed to expand and activate T regulatory cells efficiently.

Another significant patent is 'TIGIT and CD112R blockade,' focusing on novel TIGIT and CD112R binding proteins that have the potential to revolutionize immunotherapy treatments. These patents highlight Foltz's expertise in developing cutting-edge solutions for complex medical challenges.

Career Highlights:

Foltz's exceptional career includes pivotal roles at esteemed companies such as Amgen Inc. and Amgen Fremont Inc. His contributions have played a vital role in shaping the pharmaceutical landscape, with a focus on improving patient outcomes through innovative drug developments.

Collaborations:

Throughout his career, Foltz has collaborated with accomplished professionals in the field, including coworkers Chadwick Terence King and Jaspal Singh Kang. These collaborations have led to the successful implementation of novel ideas and the development of impactful medical solutions.

Conclusion:

In conclusion, Ian Nevin Foltz stands as a beacon of innovation in the realm of biochemistry and pharmaceuticals. His extensive patent portfolio and collaborative spirit underscore his commitment to advancing medical science and improving patient care. Foltz's contributions continue to inspire and drive progress in the ever-evolving field of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…